# Tamsulosin Phase III Clinical Trial -Double-Blind, Placebo Controlled Study in Female Patients With Lower Urinary Tract Syndrome

> **NCT00239265** · PHASE3 · COMPLETED · sponsor: **Astellas Pharma Inc**

## Conditions studied

- Urinary Tract Diseases

## Interventions

- **DRUG:** Tamuslosin

## Key facts

- **NCT ID:** NCT00239265
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2007-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00239265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00239265, "Tamsulosin Phase III Clinical Trial -Double-Blind, Placebo Controlled Study in Female Patients With Lower Urinary Tract Syndrome". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00239265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*